AlbuterolTabletsSulfonesPurinesPiperazinesPhosphodiesterase InhibitorsPhosphodiesterase 5 Inhibitors3',5'-Cyclic-GMP PhosphodiesterasesErectile DysfunctionBronchodilator AgentsTablets, Enteric-CoatedNebulizers and VaporizersCyclic Nucleotide Phosphodiesterases, Type 5IpratropiumAdrenergic beta-2 Receptor AgonistsAdministration, InhalationInhalation SpacersRacepinephrineMetered Dose InhalersAdrenergic beta-AgonistsChemistry, PharmaceuticalExcipientsBronchial SpasmVasodilator AgentsPenile ErectionHomosexuality, MaleDrug CompoundingOzone DepletionMethamphetamineAsthmaDelayed-Action PreparationsChlorofluorocarbonsCyclic GMPAerosol PropellantsGeorgiaTechnology, PharmaceuticalMethylcelluloseBronchoconstrictionRespiratory Therapy Department, HospitalPowdersDrug IncompatibilityAerosolsBronchiolitisDouble-Blind MethodForced Expiratory VolumeSolubilityAnti-Asthmatic AgentsForced Expiratory Flow RatesEquipment DesignUnsafe SexReceptors, Adrenergic, beta-2HardnessDrug CombinationsBeclomethasoneMasksAdministration, OralRisk-TakingModels, AnatomicLubricantsDosage FormsSexual BehaviorTherapeutic EquivalencyCapsulesMyasthenic Syndromes, CongenitalPulmonary Disease, Chronic ObstructiveAirway ResistanceRespiratory TherapyEquipment SafetyStereoisomerismCross-Over StudiesBronchial Provocation TestsCellulosePovidoneManikinsDrug StabilityBiological AvailabilityTreatment OutcomeHardness TestsAdministration, BuccalRespiratory Function TestsPropanolaminesDrug Administration ScheduleDrug Delivery SystemsParticle SizeBudesonideIntubation, IntratrachealHydrocarbons, FluorinatedCompressive StrengthMissouriPeak Expiratory Flow RateCarboxymethylcellulose SodiumSuspensionsAndrostadienesDrug Therapy, CombinationPlacebosGlucocorticoidsPolymethacrylic AcidsRespiration, ArtificialPlethysmographyPharmaceutic Aids